Y
Yohei Doi
Researcher at University of Pittsburgh
Publications - 393
Citations - 24130
Yohei Doi is an academic researcher from University of Pittsburgh. The author has contributed to research in topics: Klebsiella pneumoniae & Medicine. The author has an hindex of 71, co-authored 333 publications receiving 18441 citations. Previous affiliations of Yohei Doi include Prince of Songkla University & Fujita Health University.
Papers
More filters
Journal ArticleDOI
Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: A microbiological and molecular biological study
Yiyun Liu,Yang Wang,Timothy R. Walsh,Ling-Xian Yi,Rong Zhang,James Spencer,Yohei Doi,Guo-Bao Tian,Baolei Dong,Xianhui Huang,Lin-Feng Yu,Danxia Gu,Hongwei Ren,Xiaojie Chen,Luchao Lv,Dandan He,Hongwei Zhou,Zi-sen Liang,Jian-Hua Liu,Jianzhong Shen +19 more
TL;DR: The emergence of MCR-1 heralds the breach of the last group of antibiotics, polymyxins, by plasmid-mediated resistance, in Enterobacteriaceae and emphasise the urgent need for coordinated global action in the fight against pan-drug-resistant Gram-negative bacteria.
Journal ArticleDOI
The global epidemiology of carbapenemase-producing Enterobacteriaceae
David van Duin,Yohei Doi +1 more
TL;DR: Carbapenemase-producing Enterobacteriaceae have been most commonly associated with the Indian Subcontinent as well as with specific countries in Europe, including Romania, Denmark, Spain, and Hungary.
Journal ArticleDOI
Treatment Outcome of Bacteremia due to KPC-Producing Klebsiella pneumoniae: Superiority of Combination Antimicrobial Regimens
Zubair A. Qureshi,David L. Paterson,David L. Paterson,Brian A. Potoski,Mary C. Kilayko,Gabriel Sandovsky,Emilia Mia Sordillo,Bruce Polsky,Jennifer M. Adams-Haduch,Yohei Doi +9 more
TL;DR: The use of combination therapy for definitive therapy appears to be associated with improved survival in bacteremia due to KPC-producing K. pneumoniae.
Journal ArticleDOI
16S Ribosomal RNA Methylation: Emerging Resistance Mechanism against Aminoglycosides
Yohei Doi,Yoshichika Arakawa +1 more
TL;DR: A 2-tiered approach, consisting of disk diffusion tests followed by confirmation with polymerase chain reaction, is recommended for detection of 16S rRNA methylase-mediated resistance.
Journal ArticleDOI
Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae
David van Duin,Judith J. Lok,Michelle Earley,Eric Cober,Sandra S. Richter,Federico Perez,Federico Perez,Robert A. Salata,Robert C. Kalayjian,Richard R. Watkins,Richard R. Watkins,Yohei Doi,Keith S Kaye,Vance G. Fowler,David L. Paterson,Robert A. Bonomo,Robert A. Bonomo,Scott R. Evans +17 more
TL;DR: Ceftazidime-avibactam may be a reasonable alternative to colistin in the treatment of K. pneumoniae carbapenemase-producing CRE infections and require confirmation in a randomized controlled trial.